Dirk-Roelfs Meyer

Low-Dose Paclitaxel–Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease

Henrik Schrøeder, Martin Werner, Dirk-Roelfs Meyer et al. · Circulation · 2017 · 144 citations · Full text

Medicine, Pharmacotherapy, Surgery +16

Sustainable Antirestenosis Effect With a Low-Dose Drug-Coated Balloon

Marianne Brodmann, Martin Werner, Dirk-Roelfs Meyer et al. · JACC: Cardiovascular Interventions · 2018 · 65 citations

Medicine, Pharmacology, Pharmacotherapy +3

Six-Month Outcomes From the First-in-Human, Single-Arm SELUTION Sustained-Limus-Release Drug-Eluting Balloon Trial in Femoropopliteal Lesions

Thomas Zeller, Klaus Brechtel, Dirk-Roelfs Meyer et al. · Journal of Endovascular Therapy · 2020 · 62 citations

Medicine, Pharmacotherapy, Surgery +15

Two-Year Clinical Outcomes of the CONSEQUENT Trial: Can Femoropopliteal Lesions be Treated with Sustainable Clinical Results that are Economically Sound?

Thomas Albrecht, Matthias Waliszewski, Catherine Roca et al. · CardioVascular and Interventional Radiology · 2018 · 60 citations

Medicine, Surgery, Outcomes Research +8

Angiographic and Clinical Outcomes After Treatment of Femoro-Popliteal Lesions with a Novel Paclitaxel-Matrix-Coated Balloon Catheter

Gunnar Tepe, Özlem Gögebakan, Ulf Redlich et al. · CardioVascular and Interventional Radiology · 2017 · 56 citations

Medicine, Surgery, Interventional Cardiology +11